We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.03% | 1,728.00 | 1,727.50 | 1,728.50 | 1,739.50 | 1,724.50 | 1,733.00 | 1,116,102 | 12:12:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.47 | 71.29B |
Date | Subject | Author | Discuss |
---|---|---|---|
21/10/2020 09:48 | SP is continuously dropping,my condolences to those who bought with the dividend money,if the oncoming results are slightly negative then the 12 pound GSK share price is imminent imo ! | abdullla | |
21/10/2020 09:40 | 1300 it is then | amaretto1 | |
20/10/2020 20:21 | This reminds me of aviva, everyone keeps banging on about it being worth “ more “, and “ loading up on weakness “ bla bla, but they are both cxxp, buying stuff for dividends is a mugs game, buy growth, every time, this has become a shocker, I used to trade it now just short it when I can. | porsche1945 | |
20/10/2020 19:47 | A bid for the vaccine and pharma side of GSK would not be allowed, certainly not at this time. The only company that would be allowed to bid is AZN and they do not need nor want GSK. So for anyone looking to buy GSK in the hope of a bid, It's very unlikely. That does not stop occasional media speculation. | essentialinvestor | |
20/10/2020 18:12 | Berenberg today did not help, we know revenue going to be down next Wednesday. All in the price. | montyhedge | |
20/10/2020 17:28 | Lol. Broken recent support. Best move funds in readiness for another slug at 1300p. If it breaks that then I guess it'll get swallowed by an overseas investor/company for breakup. All imo. spud | spud | |
20/10/2020 17:25 | Your main computer?, how many do you have ). | essentialinvestor | |
20/10/2020 17:20 | Very definitely, ouch! 2.6m after the bell. I'm guessing a UT as I'm not near my main computer. spud | spud | |
20/10/2020 16:47 | Looks that way, what's that 23% off their high. | montyhedge | |
20/10/2020 16:43 | Downtrend still intact?. | essentialinvestor | |
20/10/2020 15:02 | Berenberg saying 3rd quarter figures to lag behind, we all know that, surely that's why they are 1389p, has long has the 19p dividend ok. | montyhedge | |
20/10/2020 14:13 | Now is the time for quality stock accumulation ready for when the Market regains it's ability to apply correct valuations. spud | spud | |
20/10/2020 13:46 | Interesting. | montyhedge | |
20/10/2020 13:26 | GSK having slipped down the BigPharma league table is a story in itself. Will it end up by getting truly broken up? 2 Swiss companies in the top 3 now. They were going to merge but are now too big to merge. | alphorn | |
20/10/2020 13:16 | Ah, the inimitable Mr Dury ). | essentialinvestor | |
20/10/2020 13:14 | Reasons to be cheerful, Part 2 The 'split' produces 2 leading companies to create one of the world’s leader in Consumer Healthcare, with scale and strong capabilities, powered by category leading brands and science based innovation New competitive Pharmaceuticals and Vaccines company with R&D focused on science of the immune system, genetics and advanced technologies New world-leading Consumer Healthcare company with category leading power brands and science based innovation | tradermichael | |
20/10/2020 12:59 | Reasons to be cheerful, Part 1: Product pipeline: 6 new products with on going registration around the world 11 new products at Phase III 2 potential new products at Phase II/III 17 potential products at Phase II 15 potential products at Phase I | tradermichael | |
20/10/2020 12:44 | Plenty of good GSK news. | tradermichael | |
20/10/2020 12:38 | The share price is in a lull before third quarter 2020 results on Wednesday 28 October, 2020. | tradermichael | |
20/10/2020 12:01 | On equity market opportunities I'm relatively optimistic for 2021. We have an ugly few months ahead with COVID and potentially some stock market downside/increase in volatility to first navigate. Would hope by H2 2021 some semblance of normality to everyday life will have returned. | essentialinvestor | |
20/10/2020 11:55 | Hmmm, P1945 - things will get better! | tradermichael | |
20/10/2020 11:41 | Just keeps sinking. Dividend cut imminent, weak drug pipeline, far too much debt ( the bio tech purchase Tesoro down the drain money 5.1b usd) and covid affecting prescriptions, things have really caught up with gsk and its years of cxxp management, the split will make zero difference to value, next stop for these about 12.50/80. Ftse 350 terminal, reflective of U.K. in general. | porsche1945 | |
20/10/2020 11:27 | Pfizer has already submitted one application for approval - Swissmedic said Pfizer submitted an application for the authorisation of a vaccine which is based on the mRNA technology last week. AZN has also submitted an application. (more on my thread if of interest). | alphorn |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions